Mytrex Health Technologies (ROCO:4431) Forward Dividend Yield %: 0.00% (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4431 Mytrex Health Technologies Inc ROCO:4431
64 GF Score
Price NT$17.35
GF Value NT$37.17
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Mytrex Health Technologies Forward Dividend Yield %?

Mytrex Health Technologies ROCO:4431 +2.06% 64 Forward Dividend Yield % is 0.00% as of Jul. 18, 2026. GuruFocus rates ROCO:4431 with a GF Score™ of 64/100 and a GF Value™ of NT$37.17 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 1,864 Industrial Products companies, Mytrex Health Technologies ranks worse than 53648.02% on this metric.

As of today (2026-07-18), the Forward Annual Dividend Yield of Mytrex Health Technologies is 0.00%.

As of today (2026-07-18), the Trailing Annual Dividend Yield of Mytrex Health Technologies is 0.00%.

ROCO:4431's Forward Dividend Yield % is not ranked *
in the Industrial Products industry.
Industry Median: 1.57
* Ranked among companies with meaningful Forward Dividend Yield % only.

Mytrex Health Technologies's Dividends per Share for the six months ended in Dec. 2025 was NT$0.00.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Mytrex Health Technologies was 154.90% per year. The lowest was -23.20% per year. And the median was 6.90% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Mytrex Health Technologies  (ROCO:4431) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Mytrex Health Technologies Forward Dividend Yield % Related Terms


ROCO:4431 vs GEV, ETN, PH: Forward Dividend Yield % Comparison

For the Specialty Industrial Machinery subindustry, Mytrex Health Technologies's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mytrex Health Technologies Forward Dividend Yield % vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, Mytrex Health Technologies's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Mytrex Health Technologies's Forward Dividend Yield % falls into.


ROCO:4431
64GF Score
Mytrex Health Technologies Inc ROCO:4431
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mytrex Health Technologies Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
Mytrex Health Technologies (ROCO:4431) has a Forward Dividend Yield % of 0.00% as of Jul. 18, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Mytrex Health Technologies and its competitors. According to the industry distribution chart, Mytrex Health Technologies ranks #999999 out of 1864 companies in the Industrial Products industry.
Is Mytrex Health Technologies' Forward Dividend Yield % too high?
Mytrex Health Technologies' current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Mytrex Health Technologies ranks #999999 out of 1864 companies in the Industrial Products industry, which is in the bottom quartile relative to peers. Overall, Mytrex Health Technologies has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mytrex Health Technologies' Forward Dividend Yield % compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Mytrex Health Technologies ranks #999999 out of 1864 companies for Forward Dividend Yield %. This places Mytrex Health Technologies in the lower half of its industry. The industry median Forward Dividend Yield % is 1.57. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for an Industrial Products company?
The median Forward Dividend Yield % among Industrial Products companies is 1.57, based on 1,864 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Mytrex Health Technologies and its competitors. For the Industrial Products industry, the median Forward Dividend Yield % is 1.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mytrex Health Technologies's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mytrex Health Technologies stock overvalued right now?
Based on GuruFocus' analysis, Mytrex Health Technologies (ROCO:4431) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$37.17, compared to a current price of NT$17.35 — trading 53.3% below its estimated fair value. The current Forward Dividend Yield % is 0.00%. Mytrex Health Technologies' overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Mytrex Health Technologies (ROCO:4431), the current Forward Dividend Yield % is 0.00% as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mytrex Health Technologies (ROCO:4431) Overvalued in 2026?

Based on GuruFocus' analysis, Mytrex Health Technologies stock appears to be undervalued. The current stock price of NT$17.35 is trading 53.3% below its estimated GF Value™ of NT$37.17. GuruFocus considers Mytrex Health Technologies to be Significantly Undervalued.

Key valuation signals for ROCO:4431:

  • Forward Dividend Yield %: 0.00%
  • GF Value™: NT$37.17 vs. price of NT$17.35 (53.3% below fair value)
  • GF Score™: 64/100 with 5 warning signs

No single metric tells the full story. See the ROCO:4431 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mytrex Health Technologies Business Description

Address No. 545, Section 2, Hezhen North Road, Zhongli District, Taoyuan, TWN, 32060
Mytrex Health Technologies Inc is a Taiwan-based company engaged in the manufacturing of non-woven materials and special medical supplies. It is engaged in the development and production of melt-blown products for the protection of the environment and human health. The company offers products ranging from medical to industrial filtration materials such as various types of filtration media, lab coats or outfits, cabin filtration, vacuum cleaner filter bags, and special medical supplies. Its product categories include meltdown, mammoth bedding, and specialized medical supplies like balloon catheters and coronary stents.
64GF Score

Get the complete analysis for ROCO:4431

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$17.35
Price
NT$37.17
GF Value